Vol 72, No 6 (2022)

Date published: 2022-12-13

Table of Contents

open access

Original article

Tumor-infiltrating lymphocytes and levels of PD-L1 and BRCA protein expression may identify patients with breast cancer with a higher rate of BRCA1 mutations

Polina Damyanova Dimitrova, Savelina Ljubenova Popovska, Angel Danchev Yordanov

Research paper (original)

Nowotwory. Journal of Oncology 2022;72(6):355-364.
Review article

Avelumab use in Merkel cell carcinoma treatment

Monika Dudzisz-Śledź, Martyna Zwierzchowska, Elżbieta Bylina, Piotr Rutkowski, Anna M. Czarnecka

Review paper

Nowotwory. Journal of Oncology 2022;72(6):365-371.
Radiotherapy in the combined treatment

Short-course radiotherapy as part of total neoadjuvant therapy for locally advanced rectal cancer – a new standard?

Rafał Suwiński, Marcin Zeman, Iwona Dębosz-Suwińska, Adam Idasiak

Review paper

Nowotwory. Journal of Oncology 2022;72(6):372-377.
Rare neoplasms in oncology

Treatment of metastatic uveal melanoma

Mateusz M. Polaczek, Hanna Koseła-Paterczyk

Review paper

Nowotwory. Journal of Oncology 2022;72(6):378-383.
Guidelines and recommendations

Post-treatment follow-up in common solid malignancies: expert panel recommendations

Jacek Jassem, Anna Kowalczyk, Aleksander Biesiada, Renata Duchnowska, Rafał Dziadziuszko, Agnieszka Mastalerz-Migas, Andrzej Kawecki, Maciej Krzakowski, Piotr Potemski, Piotr Rutkowski, Piotr Wysocki

Guidelines / Expert consensus

Nowotwory. Journal of Oncology 2022;72(6):384-407.
Pictures in oncology

Deeply located Merkel cell carcinoma

Rafał Robak, Tomasz Wojewoda, Wojciech M. Wysocki

Pictures in Oncology

Nowotwory. Journal of Oncology 2022;72(6):408.

Stereotactic body radiation therapy for treatment of oligometastatic EGFR-mutated non-small cell lung cancer

Artur S. Bandura, Rafał Dziadziuszko

Pictures in Oncology

Nowotwory. Journal of Oncology 2022;72(6):409.


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl